American doctors rely on clinical trials to determine which drugs to use in treatment. Researchers have found that clinical trials have not been effective in creating drugs for America’s diverse population. When clinical trials are too homogeneous, they can miss important potential discoveries. Patients who are diverse ethnically and racially can respond differently to medications, leading to dire consequences in some cases. Listen to learn how a lack of diversity in clinical trials affects patients and how researchers are trying to fix it.
Story Length: 3:21
Socrative users can import these questions using the following code: SOC-1234
Fact, Question, Response
Language Identification Organizer
Deeper Meaning Chart